KO vs SABSW · P/E 25, rev $47.94B vs P/E 0.0
The Coca-Cola Company (KO) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
SABSW does not have a complete income-statement cache yet.
KO currently screens at market cap $343.90B and trailing P/E 25.1. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the KO and SABSW stock pages for the full models.
Not investment advice.